Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway
Osteosarcoma is the most common primary malignancy of bone in children and adolescents. Others and our previous studies have shown that Yes-associated protein (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ) as core components of the Hippo pathway are crucial regulators of osteosarcoma...
Main Authors: | Yang Li, Shuting Yang, Shuying Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/8/1361 |
Similar Items
-
Verteporfin-loaded sutureless composite barrier: A novel approach to peritendinous adhesion prevention
by: Xingyu Ouyang, et al.
Published: (2023-08-01) -
Verteporfin Suppresses YAP-Induced Glycolysis in Breast Cancer Cells
by: Hong Chen, et al.
Published: (2023-12-01) -
YAP Inhibition by Verteporfin Causes Downregulation of Desmosomal Genes and Proteins Leading to the Disintegration of Intercellular Junctions
by: Yunying Huang, et al.
Published: (2022-05-01) -
Targeting the YAP/TAZ Hippo signaling pathway for oral cancer treatment
by: Muthu Thiruvengadan
Published: (2024-08-01) -
YAP1/TAZ Mediates Rumen Epithelial Cell Proliferation but Not Short-Chain Fatty Acid Metabolism In Vitro
by: Bin Yang, et al.
Published: (2024-03-01)